UTTERBODY Trademark

Trademark Overview

On Tuesday, May 5, 2026, a trademark application was filed for UTTERBODY with the United States Patent and Trademark Office. The USPTO has given the UTTERBODY trademark a serial number of 99804962. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, May 5, 2026. This trademark is owned by Utter Therapeutics Inc.. The UTTERBODY trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the field of pharmaceuticals; Research and development in the field of biotechnology
utterbody

General Information

Serial Number99804962
Word MarkUTTERBODY
Filing DateTuesday, May 5, 2026
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateTuesday, May 5, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkUTTER BODY
Goods and ServicesResearch and development in the field of pharmaceuticals; Research and development in the field of biotechnology

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, May 5, 2026
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameUtter Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94107
US

Trademark Events

Event DateEvent Description
Tuesday, May 5, 2026NEW APPLICATION ENTERED
Tuesday, May 5, 2026APPLICATION FILING RECEIPT MAILED

Related Keywords

utterbody research field development biotechnology pharmaceuticals